<?xml version='1.0' encoding='utf-8'?>
<document id="21456052"><sentence text="Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions."><entity charOffset="22-34" id="DDI-PubMed.21456052.s1.e0" text="ketoconazole" /><entity charOffset="39-47" id="DDI-PubMed.21456052.s1.e1" text="rifampin" /><entity charOffset="60-67" id="DDI-PubMed.21456052.s1.e2" text="OATP1B1" /><pair ddi="false" e1="DDI-PubMed.21456052.s1.e0" e2="DDI-PubMed.21456052.s1.e0" /><pair ddi="false" e1="DDI-PubMed.21456052.s1.e0" e2="DDI-PubMed.21456052.s1.e1" /><pair ddi="false" e1="DDI-PubMed.21456052.s1.e0" e2="DDI-PubMed.21456052.s1.e2" /><pair ddi="false" e1="DDI-PubMed.21456052.s1.e1" e2="DDI-PubMed.21456052.s1.e1" /><pair ddi="false" e1="DDI-PubMed.21456052.s1.e1" e2="DDI-PubMed.21456052.s1.e2" /></sentence><sentence text="Ketoconazole and rifampin are the most widely used compounds examined in recent drug-drug interaction (DDI) studies, and they have multiple roles in modulating drug metabolizing enzymes and transporters"><entity charOffset="0-12" id="DDI-PubMed.21456052.s2.e0" text="Ketoconazole" /><entity charOffset="17-25" id="DDI-PubMed.21456052.s2.e1" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.21456052.s2.e0" e2="DDI-PubMed.21456052.s2.e0" /><pair ddi="false" e1="DDI-PubMed.21456052.s2.e0" e2="DDI-PubMed.21456052.s2.e1" /></sentence><sentence text=" To determine the underlying mechanisms of DDI, this study was performed to investigate the inhibitory effects of ketoconazole and rifampin on the functions of OAT1 and OATP1B1, and to evaluate the potential of ketoconazole and rifampin for DDI with substrate drugs for these transporters in a clinical setting"><entity charOffset="114-126" id="DDI-PubMed.21456052.s3.e0" text="ketoconazole" /><entity charOffset="131-139" id="DDI-PubMed.21456052.s3.e1" text="rifampin" /><entity charOffset="211-223" id="DDI-PubMed.21456052.s3.e2" text="ketoconazole" /><entity charOffset="228-236" id="DDI-PubMed.21456052.s3.e3" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.21456052.s3.e0" e2="DDI-PubMed.21456052.s3.e0" /><pair ddi="false" e1="DDI-PubMed.21456052.s3.e0" e2="DDI-PubMed.21456052.s3.e1" /><pair ddi="false" e1="DDI-PubMed.21456052.s3.e0" e2="DDI-PubMed.21456052.s3.e2" /><pair ddi="false" e1="DDI-PubMed.21456052.s3.e0" e2="DDI-PubMed.21456052.s3.e3" /><pair ddi="false" e1="DDI-PubMed.21456052.s3.e1" e2="DDI-PubMed.21456052.s3.e1" /><pair ddi="false" e1="DDI-PubMed.21456052.s3.e1" e2="DDI-PubMed.21456052.s3.e2" /><pair ddi="false" e1="DDI-PubMed.21456052.s3.e1" e2="DDI-PubMed.21456052.s3.e3" /><pair ddi="false" e1="DDI-PubMed.21456052.s3.e2" e2="DDI-PubMed.21456052.s3.e2" /><pair ddi="false" e1="DDI-PubMed.21456052.s3.e2" e2="DDI-PubMed.21456052.s3.e3" /></sentence><sentence text=" Ketoconazole inhibited OATP1B1-mediated transport activity, while rifampin inhibited OAT1 and OATP1B1"><entity charOffset="1-13" id="DDI-PubMed.21456052.s4.e0" text="Ketoconazole" /><entity charOffset="67-75" id="DDI-PubMed.21456052.s4.e1" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.21456052.s4.e0" e2="DDI-PubMed.21456052.s4.e0" /><pair ddi="false" e1="DDI-PubMed.21456052.s4.e0" e2="DDI-PubMed.21456052.s4.e1" /></sentence><sentence text=" Inhibition by rifampin and ketoconazole of the uptake of olmesartan, a substrate for OAT1 and OATP1B1, was evaluated in oocytes overexpressing these transporters"><entity charOffset="15-23" id="DDI-PubMed.21456052.s5.e0" text="rifampin" /><entity charOffset="28-40" id="DDI-PubMed.21456052.s5.e1" text="ketoconazole" /><entity charOffset="58-68" id="DDI-PubMed.21456052.s5.e2" text="olmesartan" /><pair ddi="false" e1="DDI-PubMed.21456052.s5.e0" e2="DDI-PubMed.21456052.s5.e0" /><pair ddi="false" e1="DDI-PubMed.21456052.s5.e0" e2="DDI-PubMed.21456052.s5.e1" /><pair ddi="false" e1="DDI-PubMed.21456052.s5.e0" e2="DDI-PubMed.21456052.s5.e2" /><pair ddi="false" e1="DDI-PubMed.21456052.s5.e1" e2="DDI-PubMed.21456052.s5.e1" /><pair ddi="false" e1="DDI-PubMed.21456052.s5.e1" e2="DDI-PubMed.21456052.s5.e2" /></sentence><sentence text=" The K(i) values for rifampin on OAT1 and OATP1B1-mediated olmesartan uptake were 62"><entity charOffset="21-29" id="DDI-PubMed.21456052.s6.e0" text="rifampin" /><entity charOffset="59-69" id="DDI-PubMed.21456052.s6.e1" text="olmesartan" /><pair ddi="false" e1="DDI-PubMed.21456052.s6.e0" e2="DDI-PubMed.21456052.s6.e0" /><pair ddi="false" e1="DDI-PubMed.21456052.s6.e0" e2="DDI-PubMed.21456052.s6.e1" /></sentence><sentence text="2 and 4" /><sentence text="42 µM, respectively, and the K(i) value for ketoconazole on OATP1B1-mediated olmesartan uptake was 66"><entity charOffset="44-56" id="DDI-PubMed.21456052.s8.e0" text="ketoconazole" /><entity charOffset="77-87" id="DDI-PubMed.21456052.s8.e1" text="olmesartan" /><pair ddi="false" e1="DDI-PubMed.21456052.s8.e0" e2="DDI-PubMed.21456052.s8.e0" /><pair ddi="false" e1="DDI-PubMed.21456052.s8.e0" e2="DDI-PubMed.21456052.s8.e1" /></sentence><sentence text="1 µM" /><sentence text=" As measured plasma concentrations of rifampin and ketoconazole were 7"><entity charOffset="38-46" id="DDI-PubMed.21456052.s10.e0" text="rifampin" /><entity charOffset="51-63" id="DDI-PubMed.21456052.s10.e1" text="ketoconazole" /><pair ddi="false" e1="DDI-PubMed.21456052.s10.e0" e2="DDI-PubMed.21456052.s10.e0" /><pair ddi="false" e1="DDI-PubMed.21456052.s10.e0" e2="DDI-PubMed.21456052.s10.e1" /></sentence><sentence text="29 and 6" /><sentence text="4-13" /><sentence text="3 µM, respectively, the likelihood of an OATP1B1-mediated drug-drug interaction between rifampin and olmesartan is thought to be possible, whereas OAT1 or OATP1B1-mediated DDI between rifampin or ketoconazole and olmesartan appears unlikely in the clinical setting"><entity charOffset="88-96" id="DDI-PubMed.21456052.s13.e0" text="rifampin" /><entity charOffset="101-111" id="DDI-PubMed.21456052.s13.e1" text="olmesartan" /><entity charOffset="184-192" id="DDI-PubMed.21456052.s13.e2" text="rifampin" /><entity charOffset="196-208" id="DDI-PubMed.21456052.s13.e3" text="ketoconazole" /><entity charOffset="213-223" id="DDI-PubMed.21456052.s13.e4" text="olmesartan" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e0" e2="DDI-PubMed.21456052.s13.e0" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e0" e2="DDI-PubMed.21456052.s13.e1" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e0" e2="DDI-PubMed.21456052.s13.e2" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e0" e2="DDI-PubMed.21456052.s13.e3" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e0" e2="DDI-PubMed.21456052.s13.e4" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e1" e2="DDI-PubMed.21456052.s13.e1" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e1" e2="DDI-PubMed.21456052.s13.e2" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e1" e2="DDI-PubMed.21456052.s13.e3" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e1" e2="DDI-PubMed.21456052.s13.e4" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e2" e2="DDI-PubMed.21456052.s13.e2" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e2" e2="DDI-PubMed.21456052.s13.e3" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e2" e2="DDI-PubMed.21456052.s13.e4" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e3" e2="DDI-PubMed.21456052.s13.e3" /><pair ddi="false" e1="DDI-PubMed.21456052.s13.e3" e2="DDI-PubMed.21456052.s13.e4" /></sentence><sentence text="" /></document>